compound semaglutide being discontinued Is Compounded Discontinued? Compounded Semaglutide Injection: GLP-1 weight

Patients should also consider medical oversight, treatment quality, convenience, and ongoing support

Please verify your specific plans coverage with your insurer or through Klaritys benefits check before booking

In the global TRIUMPH-4 trial, adults with obesity and knee osteoarthritis treated with the highest dose of retatrutide lost an average of 28.7% of their body weight over 68 weeks roughly 32 kg per patient while also showing marked improvements in pain and physical function related to osteoarthritis

By staying informed and proactive about your medication, we can work together to support your journey toward a healthier lifestyle

NM_000164.4)

retatrutide remains investigational and Lillys brand version is pending FDA review